Literature DB >> 19891237

Osteoporosis in patients with systemic lupus erythematosus.

Mario García-Carrasco1, Claudia Mendoza-Pinto, Ricardo O Escárcega, Mario Jiménez-Hernández, Ivet Etchegaray Morales, Pamela Munguía Realpozo, Jaime Rebollo-Vázquez, Elena Soto-Vega, Margarita Delezé, Ricard Cervera.   

Abstract

In recent years the survival of patients with systemic lupus erythematosus has increased markedly. Consequently, long-term complications, such as osteoporosis, are currently of paramount importance. SLE is known to increase the risk of bone fractures, and numerous studies have found that SLE patients have osteoporosis. Of the various risk factors associated with osteoporosis in SLE, disease duration, the use of corticosteroids and chronic disease-related damage are consistently reported, with differences between studies probably due to the different populations studied. The role of chronic inflammation in osteoporosis is also important. On the other hand, little attention has been paid to osteoporotic fractures, especially of the vertebra, which are associated with reduced quality of life, increased mortality rates and increased risk of new vertebral and non-vertebral fractures in the general population.

Entities:  

Mesh:

Year:  2009        PMID: 19891237

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  16 in total

Review 1.  Inflammatory bone loss: pathogenesis and therapeutic intervention.

Authors:  Kurt Redlich; Josef S Smolen
Journal:  Nat Rev Drug Discov       Date:  2012-03-01       Impact factor: 84.694

Review 2.  The multiple faces of autoimmune-mediated bone loss.

Authors:  Georg Schett; Jean-Pierre David
Journal:  Nat Rev Endocrinol       Date:  2010-11-02       Impact factor: 43.330

Review 3.  Macrophages and skeletal health.

Authors:  Megan N Michalski; Laurie K McCauley
Journal:  Pharmacol Ther       Date:  2017-02-07       Impact factor: 12.310

4.  Significantly higher estimated 10-year probability of fracture in lupus patients with bone mineral density comparable to that of healthy individuals.

Authors:  Anselm Mak; Jia Qing Lim; Yang Liu; Alicia Ai-cia Cheak; Roger Chun-man Ho
Journal:  Rheumatol Int       Date:  2012-03-24       Impact factor: 2.631

Review 5.  Fracture risk and bone mineral density levels in patients with systemic lupus erythematosus: a systematic review and meta-analysis.

Authors:  X Wang; S Yan; C Liu; Y Xu; L Wan; Y Wang; W Gao; S Meng; Y Liu; R Liu; D Xu
Journal:  Osteoporos Int       Date:  2016-01-11       Impact factor: 4.507

6.  Bone Marrow-Derived Mesenchymal Stem Cells From Patients With Systemic Lupus Erythematosus Have a Senescence-Associated Secretory Phenotype Mediated by a Mitochondrial Antiviral Signaling Protein-Interferon-β Feedback Loop.

Authors:  Lin Gao; Anna K Bird; Nida Meednu; Kristin Dauenhauer; Jane Liesveld; Jennifer Anolik; R John Looney
Journal:  Arthritis Rheumatol       Date:  2017-07-11       Impact factor: 10.995

7.  Inflammatory bone loss associated with MFG-E8 deficiency is rescued by teriparatide.

Authors:  Megan N Michalski; Anna L Seydel; Erica M Siismets; Laura E Zweifler; Amy J Koh; Benjamin P Sinder; J Ignacio Aguirre; Kamran Atabai; Hernan Roca; Laurie K McCauley
Journal:  FASEB J       Date:  2018-02-22       Impact factor: 5.191

8.  Soluble receptor activator of nuclear factor κB ligand/osteoprotegerin ratio is increased in systemic lupus erythematosus patients.

Authors:  Diana Carmona-Fernandes; Maria José Santos; Inês Pedro Perpétuo; João Eurico Fonseca; Helena Canhão
Journal:  Arthritis Res Ther       Date:  2011-10-25       Impact factor: 5.156

9.  Osteonecrosis in systemic lupus erythematosus: an early, frequent, and not always symptomatic complication.

Authors:  Paola Caramaschi; Domenico Biasi; Ilaria Dal Forno; Silvano Adami
Journal:  Autoimmune Dis       Date:  2012-08-05

10.  Ovarian Damage During chemotherapy in Autoimmune Diseases: Broad Health Implications beyond Fertility.

Authors:  Wendy Marder; Senait Fisseha; Martha A Ganser; Emily C Somers
Journal:  Clin Med Insights Reprod Health       Date:  2012-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.